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Objectives: Although there is a general focus on early diagnosis and treatment of hip osteoarthritis, 
there are no validated diagnostic criteria for early-stage hip OA. The current study aimed to take the 
first steps in developing diagnostic criteria for early-stage hip OA, using factors obtained through 
history taking, physical examination, radiography and blood testing at the first consultation in 
individuals presenting with hip pain, suspicious for hip OA, in primary care. 
Methods: Data of the 543 individuals with 735 symptomatic hips at baseline who had any follow-up 
data available from the prospective CHECK cohort study were used. A group of 26 clinical experts 
(GPs, Rheumatologists and Orthopedic surgeons) evaluated standardized clinical assessment forms of 
all subjects on the presence of clinically relevant hip OA 5 to 10 years after baseline. Using the expert 
based diagnoses as reference standard, a backward selection method was used to create predictive 
models based on pre-defined baseline factors from history taking, physical examination, radiography 
and blood testing. 
Results: Prevalence of clinically relevant hip OA during follow-up was 22%. Created models contained 
4 to 8 baseline factors (mainly WOMAC pain items, painful/restricted movements, and radiographic 
features) and obtained area under the curve between 0.62 ± 0.002 and 0.71 ± 0.002. 
Conclusion: Based on clinical and radiographic features of hip OA obtained at first consultation at a 
GP for pain/stiffness of the hip, the prediction of clinically relevant hip OA within 5 to 10 years was 
‘poor’ to ‘fair’. 
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• There is currently no accepted or validated reference standard for early-stage hip OA 
• Early diagnosis could facilitate early treatment, and structural changes to the joint might still 
be reversible. 
• Questionnaires, physical examination, and radiography were limited in identifying subjects 
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The lifetime risk for hip osteoarthritis (OA) has been estimated as one in four, with prevalence 
increasing with age (1, 2). In theory, like knee OA, diagnosing hip OA earlier in the disease process 
would allow for targeted treatment options with potential greater effectiveness, as joint damage is 
not yet irreversible and pain has not become chronic (3, 4).  
Traditionally, hip OA is diagnosed based on radiographic features, like the Kellgren and Lawrence 
score (5). Altman and colleagues showed that the combination of radiographic and clinical features 
best discriminated between patients with hip pain due to OA and those with hip pain due to other 
causes (6). More recently, a focus on clinical features useful for the diagnosis of hip OA has emerged 
(7-10), as most individuals with hip OA are treated in primary care where guidelines recommend 
against the use of radiography for OA diagnosis (11, 12). Specific clinical signs and symptoms, like 
limited range of motion (ROM), tenderness in the groin, and age over 60 years, predicted the 
presence of radiographic hip OA in patients with hip pain aged ≥50 years and under treatment of a 
general practitioner (GP) (8). In other studies among patients in primary care, ROM tests alone were 
also proven to be diagnostic for the presence of radiographic features of hip OA (7, 9).  
Unfortunately, these studies on the use of clinical signs and symptoms for diagnosing hip OA showed 
lower specificity for diagnosing early or mild OA (8, 9). This is not surprising, as structural features of 
hip OA (used reference standard in these studies) develop slowly over time and are generally seen as 
manifestations of late-stage disease (13) and the known discordance between symptoms and 
structural features on radiography (14). Therefore, there is currently no accepted or validated 
reference standard for early-stage hip OA.  
The current study used an expert based diagnosis of clinically relevant hip OA 5 to 10 years after the 
first consultation in primary care with pain/stiffness of the hip as the reference standard (future 
diagnosis). Next, using the expert based diagnosis as reference standard, we aimed to find possible 
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consultation. As the set of predicting factors have been collected at first consultation and the 
outcome was established 5 to 10 years later, the criteria should be seen as diagnostic criteria for 
early-stage hip OA. 
Methods 
Cohort 
For this study, 543 (out of 588) individuals from the CHECK cohort, with 735 symptomatic hips at 
baseline,  had follow-up data available. Characteristics of the CHECK cohort, a Nationwide Dutch 
cohort of patients with hip complaints in primary care, have been described previously (15). Briefly, 
individuals were eligible if they had pain or stiffness of the hip, were aged 45–65 years, and had no 
prior consultation (when recruited via media campaign) or a first consultation with the general 
practitioner for these symptoms no longer than 6 months before recruitment. Exclusion criteria 
were: presence of any other clear pathological condition that could explain the existing complaints 
(assessed through history taking and/or physical examination), co-morbidity that did not allow 
physical evaluation or follow-up of at least 10 years, malignancy in the past 5 years, and inability to 
understand the Dutch language. Patients were followed for 10 years at regular intervals. 
Baseline measures 
All subjects completed the pain and stiffness (Likert) scales of the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC) questionnaire (not limb or joint specific)(16) and 
additional questions on demographics, physical activity, comorbidities, smoking status, and alcohol 
consumption. All hips were physically examined to evaluate the presence of pain at passive flexion, 
internal rotation, external rotation, and abduction, passive range of motion (ROM) for flexion, 
internal rotation, external rotation, and abduction, and body mass index (BMI) was determined (15). 
Standardized weight-bearing anterior-posterior (AP) and faux profil (FP) oblique view radiographs 
were centrally graded (matched read with T2, sequence known) for the presence of femoral 
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hip joint (grades 0-3), and Kellgren & Lawrence (KL) grading (grades 0-4)(5, 17). Statistical shape 
models determined the presence of CAM morphology (Alpha angle >60°) and hip dysplasia (Wiberg 
angle <25°) on each AP radiograph as previously described (18, 19). Finally, high-sensitive C-reactive 
protein (hsCRP) was determined after a vena-puncture to establish systemic inflammation. 
Follow-up measures 
At 5, 8 and 10 years after baseline, the above procedure was repeated, and patients were 
additionally questioned for the current presence of hip pain (left/right), subluxation, osteochondritis 
dissecans, intra-articular fractures, bacterial arthritis, Perthes disease, plica syndrome, and Baker’s 
cyst.  
Expert diagnoses 
A group of 24 experts was recruited; 13 general practitioners (GPs) and 11 secondary care physicians 
(6 rheumatologists and 5 orthopedic surgeons). Before evaluation of the medical records, all experts 
were queried on the number of years treating OA patients, number of OA patients treated per week, 
and their personal assessment of the importance of radiography to diagnose OA (‘not important’, 
‘little importance’, ‘some importance’, ‘very important’). 
In the first phase, all experts individually evaluated the medical records for 40-50 CHECK participants; 
of these, 7 records were evaluated by all experts. Software was developed in-house to optimally 
present demographics and all follow-up measures for each individual. First, the clinical data 
(questionnaires and physical examination) were presented to the experts. For each joint, the expert 
then answered the question “Is clinically relevant OA present in this hip?” for each joint (y/n) and 
provided a certainty of his/her diagnosis, ranging from 1 (‘definitely no clinically relevant OA’) to 100 
(‘definitely clinical relevant OA’) into the software system. To solely rely on the expertise of the 
involved experts, no formal definition of ‘clinically relevant OA’ was provided to the experts. 
Next, the radiographic data for the individual were made available: KL grading and the scores for JSN 
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the question on the diagnosis of OA and its certainty were repeated for each joint. At that time, the 
clinical data and corresponding OA diagnoses were still available on a read-only basis. 
After completion, the second phase assessed agreement within expert pairs; each pair had one GP 
and one secondary care physician, except one with two GPs. All cases where the expert pair 
disagreed on the diagnosis were re-evaluated, except those labelled ‘uncertain’; this pre-defined 
label included all cases where experts disagreed, but both with certainty >30 and <70. Re-evaluation 
comprised a consensus meeting by conference call (with online access to the data). The expert pair 
followed the same procedure as before, but now with their individual diagnoses and certainty scores 
made visible. Cases where consensus could still not be reached were also labelled as ‘uncertain’. 
Statistics 
Baseline factors were limited to predefined factors previously described as diagnostic or prognostic 
for hip OA. These factors were checked for completeness and missing values were replaced through 
multiple imputation (creating 50 data sets, as 62% of cases had incomplete data, but only six 
variables had >10% of missing values). Next, categorical factors were dichotomized based on 
literature and authors’ expertise. For WOMAC pain and morning stiffness items, absence of 
pain/stiffness was defined by merging the ‘none’ and ‘slight’ categories. Presence of ‘restricted or 
painful flexion’ was defined as maximal hip flexion ≤115 degrees and/or pain at hip flexion.  Presence 
of ‘restricted or painful internal rotation’ was defined as maximal hip internal rotation ≤15 degrees 
and/or pain at hip internal rotation. Presence of ‘restricted or painful external rotation’ was defined 
as maximal hip external rotation ≤15 degrees and/or pain at hip external rotation. Presence of 
‘restricted or painful abduction’ was defined as maximal hip abduction ≤10 degrees and/or pain at 
hip abduction (6, 20). Osteophytes and JSN were defined presence in the presence of a grade ≥2 
(equals ‘minimal’ or greater).  Multicollinearity between factors (Variance Inflation Factor > 10) was 
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To identify early-stage diagnostic factors for the presence of clinically relevant hip OA 5-10 years 
later, models to predict the expert diagnosis as outcome were created in a stepped approach; first all 
factors obtained from questionnaires and physical examination were used (model 1). Next, all 
radiographic factors were added (model 2) and finally hsCRP (model 3). All models applied a 
backward selection method (p > 0.1 for removal). To correct for repeated measures within subjects 
due to possible bilateral complaints, Generalized Estimating Equations were used. For each model 
area under the receiver-operating curve (AUC) was calculated and odds ratio plus 95% confidence 
interval for each factor within the models was presented.  
In sensitivity analyses, continuous measures for age, BMI, duration of complaints and hsCRP were 
dichotomized. For age and duration of complaints, the upper tertile were compared to the lower two 
tertiles. BMI was dichotomized using two different cut-offs: <25 vs. ≥25 kg/m2 and <30 vs. ≥30 kg/m2. 
hsCRP was dichotomized using ≤3 mg/L vs. >3 mg/L(21). 
Results 
For the 543 selected individuals, mean (SD) baseline age was 55.7 (5.2) years, BMI was 26.3 (4.1) 
kg/m2, median duration of complaints was 20 months (interquartile range 26), and average WOMAC 
pain and stiffness (0-100) scores were 27.5 (17.2) and 35.5 (21.0), respectively. Baseline prevalence 
of the other selected factors, pooled after multiple imputation, are presented in Table 1. Mean 
baseline concentration for hsCRP was 3.4 (7.9) mg/L. 
The experts had 18 (10) years of experience treating OA patients and treated median 5 (interquartile 
range 13) OA patients per week. Prior to evaluating the medical records, most experts deemed 
radiographs important for the diagnosis (63% somewhat, 17% very important). The remainder (21%) 
found radiographs to be of minor importance. Both hips of 7 individuals were evaluated by all 12 
expert pairs (168 diagnoses). There was agreement between expert pairs in 79% of these diagnoses 
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Figure 1 presents the consensus-based diagnosis for all 735 selected hip joints. Based on the clinical 
plus radiographic assessment, 22% of all hips had clinically relevant OA and in 11% the final diagnosis 
was uncertain. For optimal contrast, the cases diagnosed without clinically relevant hip OA were 
compared to the cases diagnosed with clinically relevant hip OA, ignoring the uncertain cases. Several 
clinical and radiographic baseline features were significantly associated with the diagnosis based on 
the clinical assessment (Table 2) and that based on the clinical plus radiographic assessment by the 
experts (Table 3). However, diagnostic accuracy of the models was modest. HsCRP did not end up in 
any model. Categorizing the continuous variables in the sensitivity analyses did not materially affect 
the models or their AUC (data not shown).  
 
Discussion 
The current study showed that, based on clinical and radiographic features of hip OA obtained at first 
consultation at a GP for pain/stiffness of the hip, the prediction of clinically relevant hip OA within 5 
to 10 years was ‘poor’ to ‘fair’. 
The expert based diagnosis of clinically relevant hip OA, used as reference standard, forms both a 
strength and a weakness of the current study. Given the slow development of structural features of 
OA, the discordance between signs and symptoms, and the fluctuating nature of OA pain, having 
clinical experts evaluating individual’s clinical course of signs, symptoms and radiographic features 
over a 5-year period to establish a diagnosis of clinically relevant hip OA seemed the optimal method 
to establish a reliable reference standard. With an average of 18 years of experience in treating hip 
OA patients, the experts seemed well equipped to establish a reliable diagnosis. Of course, the lack 
of an external validation of the expert based diagnoses is a limitation to the current study. 
Despite the fact that 60% of CHECK participants had radiographic hip OA after 10 years of follow-up, 
only 16% of CHECK participants fulfilled the clinical ACR criteria for hip OA at that time point (22). 
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during the 5 to 10 years period (22%) was a little higher than prevalence of the clinical ACR criteria at 
10 years. Still, the prevalence of clinically relevant hip OA was remarkably lower than the prevalence 
of radiographic hip OA. This adds to the existing knowledge, mainly coming from knee OA studies 
(13, 23), that there is mismatch between clinical symptoms and radiographic features of hip OA (14). 
Alternatively, one could argue that the experts might have under diagnosed the presence of clinically 
relevant hip OA. However, if we also consider the ‘uncertain cases’ to be cases of hip OA, still the 
prevalence will only be 33%, which remains lower than the prevalence of radiographic hip OA within 
this cohort. 
The obtained models did not perform as good as anticipated in separating individuals that developed 
clinically relevant hip OA within 5 to 10 years from those who did not. Even though all previously 
identified factors for relevant for diagnosing hip OA (e.g. ROM, duration of symptoms, pain 
characteristics (7-9)) and factors predictive for hip OA development (e.g. BMI, female sex, morning 
stiffness, painful/restricted ROM, dysplasia, CAM deformities (18, 19, 24, 25)) were incorporated in 
the analyses. Similar methods did result in ‘fair’ to ’good’ prediction of clinically relevant knee OA 
(26). Possibly, incorporating the two-years’ course of hip symptoms after the first consultation into 
the models can increase the discriminating abilities. Also, choosing stricter cut-of scores for the 
predictive factors, e.g., ≤20 degrees to define the presence of dysplasia or ≥severe pain for the 
presence of pain, could improve the AUC values. However, this will lower the number of individuals 
that will meet these criteria and hence limiting the clinical applicability. A recent systematic review 
identified abductor weakness and pain when squatting as factor with potential diagnostic value (high 
specificity, low sensitivity), which were not incorporated in the current study (10).  
Previous studies did show that factors like limited ROM (either in a single plain or in multiple 
planes)(7, 9) or a combination of factors from history taking and physical examination (8, 10) did 
have acceptable to good diagnostic abilities for diagnosing hip OA. As indicated, all these factors 
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likely contributed to this discrepancy: 1) the outcome measure/reference standard, 2) handling of 
the predictors, and 3) the study design. Previous studies using clinical features to diagnose hip OA all 
used radiographic features of hip OA as a reference standard (7-10). Apparently, it is easier to predict 
the presence of radiographic features of hip OA based on clinical features than the presence of 
clinically relevant hip OA, which will be strongly influenced by the presence of pain and functional 
limitations. In contrast to some of the previous studies, predicting factors based on ROM were 
dichotomized in the present study. Despite the potential loss of statistical power, the clinical 
feasibility of a dichotomous factor was deemed of greater importance. Finally, the indicated studies 
all had a cross-sectional design (7-9). In the present study, we intended to create criteria to diagnose 
early-stage hip OA. As there is no validated reference standard for early-stage hip OA available, the 
best available option is to relate potential diagnostic factors to a relevant outcome in the future. 
Intuitively, a period of 5 to 10 years between the assessment of potential diagnostic factors and the 
establishment of the reference standard will reduce the strength of their association compared to a 
cross-sectional assessment of both factors. 
From the presented models in Tables 2 and 3, it is notable that some associations were 
counterintuitive. For example, the presence of pain at rest or superior JSN were associated with 
reduced odds for having clinically relevant hip OA after 5 to 10 years. However, one must keep in 
mind that these are factors within a multivariable model; the presented associations are only true 
when adjusted for the other factors in the model. This is illustrated by the non-significant 
associations of pain at rest, pain when walking and superior JSN with the presence of clinically 
relevant hip OA when tested univariate (i.e. single factor models; data not shown). 
In conclusion, features obtained through history taking, physical examination, radiography and blood 
testing at the first consultation in individuals presenting with hip pain, suggestive for early-stage hip 
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marginally. Additional factors need to be identified to come to acceptable diagnostic criteria for 
early-stage hip OA in primary care. 
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Figure 1. Percentages for expert diagnoses based on clinical data (upper row), on clinical and 
radiographic data (middle row), and summed (bottom row). Blue bars represent hips without OA, 
yellow bars represent hips with an uncertain diagnosis, and red bars represent hips with OA. 
 
 
Table 1. Baseline pooled prevalence for selected factors, presented as percentage of hips with the 
factor out of 735 hips. 
 Pooled prevalence (%) 
Questionnaire and physical examination items 
Sex (Female) 81% 
Bilateral pain 52% 







Painful/restricted abductiond 44% 
WOMAC paine  
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 standing 23% 
 stairs 44% 
 night 38% 
 rest 32% 
WOMAC stiffnesse  
 morning stiffness 50% 
  
Radiography items 
Femoral osteophytesf 14% 
Medial JSNf 8% 
Superior JSNf 4% 
CAM morphologyg 11% 
Dysplasiah 7% 
WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index. JSN: joint space 
narrowing. a defined as maximal hip flexion ≤115 degrees or pain at hip flexion. b maximal hip internal 
rotation ≤15 degrees or pain at hip internal rotation. c maximal hip external rotation ≤15 degrees or 
pain at hip external rotation. d maximal hip abduction ≤10 degrees or pain at hip abduction. e 
presence defined as ≥moderate pain/stiffness. f presence defined as ≥’minimal’. g presence defined 
as Alpha angle >60°. h presence defined as Wiberg angle <25°. 
 
Table 2. Obtained models for developing clinically relevant hip OA after 5 to 10 years based on the 
evaluation of clinical data only. 
 Odds ratio 95% confidence interval 
Questionnaire and physical examination items 
WOMAC pain – walking 0.57 0.33 – 0.98 
WOMAC pain – climbing stairs  2.44 1.57 – 3.80 
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WOMAC pain – rest 0.58 0.35 – 0.98 
Painful/restricted flexion 1.73 1.12 – 2.68 
Painful/restricted abduction 1.72 1.14 – 2.60 
Pooled AUC (± pooled SD) 0.698 ± 0.007 
   
Questionnaire, physical examination and radiographic items 
WOMAC pain – walking 0.62 0.36 – 1.07 
WOMAC pain – climbing stairs  2.43 1.55 – 3.80 
WOMAC pain – night 2.24 1.37 – 3.65 
WOMAC pain – rest 0.56 0.33 – 0.94 
Painful/restricted flexion 1.76 1.13 – 2.74 
Painful/restricted abduction 1.81 1.19 – 2.74 
Femoral osteophytes 1.70 1.03 – 2.80 
JSN superior 0.29 0.09 – 0.94 
Pooled AUC (± pooled SD) 0.714 ± 0.007 
WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index. JSN: joint space 
narrowing. AUC: Area under the curve. SD: standard deviation.  
 
Table 3. Obtained models for developing clinically relevant hip OA after 5 to 10 years based on the 
evaluation of clinical and radiographic data. 
 Odds ratio 95% confidence interval 
Questionnaire and physical examination items 
WOMAC pain – standing 1.63 0.98 – 2.72 
WOMAC pain – night 1.56 0.97 – 2.50 
WOMAC pain – rest 0.59 0.35 – 1.01 
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Age 1.03 1.00 – 1.07 
Bilateral complaints 0.64 0.41 – 0.98 
Pooled AUC (± pooled SD) 0.620 ± 0.002  
   
Questionnaire, physical examination and radiographic items 
Painful/restricted flexion 1.70 1.04 – 2.77 
Painful/restricted internal rotation  1.38 0.94 – 2.03 
Bilateral complaints 0.66 0.43 – 1.01 
Femoral osteophytes 2.20 1.50 – 3.22 
Pooled AUC (± pooled SD) 0.626 ± 0.010  
WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index. JSN: joint space 
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